Does ROSUVASTATIN Cause Type iia hyperlipidaemia? 63 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 63 reports of Type iia hyperlipidaemia have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.2% of all adverse event reports for ROSUVASTATIN.
63
Reports of Type iia hyperlipidaemia with ROSUVASTATIN
0.2%
of all ROSUVASTATIN reports
54
Deaths
14
Hospitalizations
How Dangerous Is Type iia hyperlipidaemia From ROSUVASTATIN?
Of the 63 reports, 54 (85.7%) resulted in death, 14 (22.2%) required hospitalization.
Is Type iia hyperlipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 63 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Type iia hyperlipidaemia?
ATORVASTATIN (67)
EZETIMIBE (67)
EVOLOCUMAB (66)
SIMVASTATIN (63)
LOMITAPIDE (59)
LOVASTATIN (56)
PROBUCOL (56)
IMPLITAPIDE (49)
CAFFEINE\PROCAINE (10)
TOCILIZUMAB (8)
Which ROSUVASTATIN Alternatives Have Lower Type iia hyperlipidaemia Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN